Proof-of-Concept Clinical Trials

Signs of activity. Groundwork for definitive studies.

Proof-of-concept clinical trials are carefully designed to establish the safety of drug candidates in the target population and explore the relationship between the dose and desired activity, as either measured directly or by means of a surrogate. Our scientific team can collaborate with your experts to design efficient studies that can be deployed in the right jurisdiction, including our Phase I clinics where complex studies involving confinement and extensive procedures can be carried out in a controlled and safe environment.

The inVentiv Health Clinical team works with you to design and implement studies that mitigate risk, help you make go/no-go decisions earlier, and avoid costly late-stage clinical development failures. Our dedicated clinical, scientific, and regulatory experts have the knowledge across a range of therapeutic indications. Collaborations, such as our partnership with Maisonneuve-Rosemont Hospital (HMR), can provide sponsors with enhanced access to study participants with special indications such as impaired renal function.

Phase I-IIa Brochure